Impact of Hepatitis Coinfection on Healthcare Utilization Among Persons Living With HIV

Abstract:Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection are increasingly important sources of morbidity among HIV-infected persons. We determined associations between hepatitis coinfection and healthcare utilization among HIV-infected adults at 4 US sites during 2006–2011. Outpatient HIV visits did not differ by hepatitis serostatus and decreased over time. Mental health visits were more common among HIV/HCV coinfected persons than among HIV monoinfected persons [incidence rate ratio (IRR): 1.27, 95% confidence interval (CI): 1.08 to 1.50]. Hospitalization rates were higher among all hepatitis-infected groups than among HIV monoinfected (HIV/HBV: IRR: 1.23, 95% CI: 1.05 to 1.44; HIV/HCV: IRR: 1.22, 95% CI: 1.10 to 1.36; HIV/HBV/HCV: IRR: 1.31, 95% CI: 1.02 to 1.68). These findings may inform the design of clinical services and allocation of resources.

[1]  Stephen A. Berry,et al.  Impact of Hepatitis Coinfection on Hospitalization Rates and Causes in a Multicenter Cohort of Persons Living With HIV , 2014, Journal of acquired immune deficiency syndromes.

[2]  A. Labriola,et al.  Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts >=300 cells/μL and HIV-1 suppression? , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Chien-Jen Chen,et al.  Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. , 2012, The Journal of infectious diseases.

[4]  B. Schackman,et al.  What does U.S. health reform mean for HIV clinical care? , 2012, Journal of acquired immune deficiency syndromes.

[5]  Cho Naing,et al.  Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis. , 2012, World journal of gastroenterology.

[6]  A. Rieger,et al.  Considerable Under-Treatment of Chronic HCV Infection in HIV Patients despite Acceptable Sustained Virological Response Rates in a Real-Life Setting , 2011, Antiviral therapy.

[7]  J. Ward,et al.  Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999–2007 , 2011, Journal of viral hepatitis.

[8]  David L. Thomas,et al.  Hepatitis C in HIV-infected individuals: cure and control, right now , 2011, Journal of the International AIDS Society.

[9]  M. Olfson,et al.  National trends in outpatient psychotherapy. , 2010, The American journal of psychiatry.

[10]  O. Kirk,et al.  HBV or HCV Coinfections and Risk of Myocardial Infarction in HIV-Infected Individuals: The D:A:D Cohort Study , 2010, Antiviral therapy.

[11]  B. Rice,et al.  HIV transmission and high rates of late diagnoses among adults aged 50 years and over , 2010, AIDS.

[12]  A. Westfall,et al.  Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV‐infected patients , 2010, HIV medicine.

[13]  O. Kirk,et al.  Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study , 2010, AIDS.

[14]  A. Wald,et al.  Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population. , 2009, AIDS patient care and STDs.

[15]  P. Morlat,et al.  Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study. , 2009, Journal of hepatology.

[16]  V. Sharp,et al.  Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States. , 2008, World journal of gastroenterology.

[17]  Xiao-Li Meng,et al.  Disparity in depression treatment among racial and ethnic minority populations in the United States. , 2008, Psychiatric services.

[18]  E. Bini,et al.  Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. , 2007, Journal of hepatology.

[19]  V. Soriano,et al.  Liver cirrhosis in HIV‐infected patients: prevalence, aetiology and clinical outcome , 2007, Journal of viral hepatitis.

[20]  M. Moroni,et al.  Chronic coinfection with hepatitis B and hepatitis C viruses in an Italian population of HIV-infected patients. , 2007, Journal of acquired immune deficiency syndromes.

[21]  John T Brooks,et al.  Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study , 2006, Journal of acquired immune deficiency syndromes.

[22]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[23]  D. Clifford,et al.  The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects , 2005, AIDS.

[24]  S. Hernandez,et al.  Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain , 2005, AIDS.

[25]  R. Kessler,et al.  Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[26]  A. Mocroft,et al.  Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort , 2005, AIDS.

[27]  A. Wohl,et al.  Survival in patients with HIV infection and viral hepatitis B or C: a cohort study , 2004, AIDS.

[28]  Richard D Moore,et al.  Hospitalization Rates Differ by Hepatitis C Status in an Urban HIV Cohort , 2003, Journal of acquired immune deficiency syndromes.

[29]  K. Petoumenos,et al.  HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy , 2003, HIV medicine.

[30]  A. d’Arminio Monforte,et al.  Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. , 2002, Archives of internal medicine.

[31]  J. Goedert,et al.  End-stage liver disease in persons with hemophilia and transfusion-associated infections. , 2002, Blood.

[32]  J. Phair,et al.  HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) , 2002, The Lancet.

[33]  P. Reiss,et al.  Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection , 2000, AIDS.

[34]  D. Vlahov,et al.  The natural history of hepatitis C virus infection: host, viral, and environmental factors. , 2000, JAMA.

[35]  J. Gallant,et al.  Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  S. Satapathy,et al.  Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection , 2011, Hepatology International.

[37]  R. Bruno,et al.  Natural history of chronic hepatitis B in co-infected patients. , 2006, Journal of hepatology.